- Exchange: Mexico
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Novartis AG (NVSN)
| Open: | - | Day's Range: | - | Volume: | 1,537 |
|---|---|---|---|---|---|
| Previous Close: | 927.38 | 52wk Range: | 733.00 - 930.33 | 1-Yr Rtn: | - |
Key Statistics for NVSN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.4407 |
| Relative P/E vs. MEXBOL | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 5.1300 |
| Est. PEG Ratio | 2.8150 |
| Market Cap (M MXN) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 1,421 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 3.37% |
| Cash Dividend (USD) | 2.0575 |
| Last Dividend | 02/26/2013 |
| 5 Year Dividend Growth | 13.61% |
| Next Earnings Announcement | 07/17/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NVSN
Company Profile & Key Executives for NVSN
Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases, oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis, vaccines and diagnostics, vision, and animal health products.
| Joseph Jimenez Jr "Joe"Chief Executive Officer | Harry KirschChief Financial Officer |
| Mark C FishmanPresident:Nibr | Bruno HeynenSecretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NVSN News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page